Details for 2012742394
Up to date per 01.04.2026
Actions
Details for 2012742394
Granted/Registered
European Patent
11.12.2013 A
16.03.2022 B1
15.07.2011
US
201161508542 P
06.01.2012
US
201261584119 P
14.11.2011
US
201161559670 P
31.01.2011
US
201161438203 P
A61K 31/4418 20060101AFI20150116BHEP
Owner
Avalyn Pharma Inc.701 Pike Street, Suite 1500 Seattle, WA 98101US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
SURBER, Mark, William4647 Edison Street San Diego, CA 92117US
Information about Fees